FDA Drug recall D-0473-2018
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only
- FDA Drug
- Class III
- terminated
- Published 2018-02-28
On 2018-02-28 the FDA classified a Class III recall of Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only by Nostrum Laboratories, citing presence of Foreign Tablets/Capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0473-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-02-13 |
| Published | 2018-02-28 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Nostrum Laboratories |
| Distribution | US |
Product
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
Reason
Presence of Foreign Tablets/Capsules
Identifiers
| code_info | Lot: CAL173502; Exp. 09/19 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0473-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.